content_copy Investor Relations - Vitro Biopharma

Investor Relations

Vitro Biopharma is a clinical-stage biotechnology company focused on developing novel and proprietary best-in-class products. Vitro develops and commercializes adult stem cell technology for applications in stem cell research and drug development for the treatment of a vast variety of diseases and conditions. The company’s innovative and proprietary technology platform leverage umbilical cord-derived stem cells, AlloRX® Stem Cells, translating ground-breaking science into medicines that transform the lives of patients with various disease. The cells when stored properly have an indefinite shelf life and are young, providing the most potent, vibrant stem cells in contrast to autologous. The current stem cell pipeline can be used to treat a multitude of diseases and is advancing multiple clinical trials across its product portfolio.  



Become an Investor

Modern stem cell technology is rapidly evolving and holds promise to revolutionize medicine by allowing regeneration of any type of cell within the human body. Vitro Biopharma provides commercialized cell lines, media, stem cell products and stem cell technology to some of the world leading institutions. Become a Vitro Biopharma investor today. Call (1)866-848-7627 or email john@vitrobiopharma.com or leave us a message here.